Similar articles for PMID: 29367950

Year	Number of Results
2009	1
2010	1
2011	4
2012	4
2013	3
2014	4
2015	13
2016	14
2017	9
2018	9
2019	11
2020	1
2021	2
2022	6
2023	1
2024	0

1

KRAS Cold Turkey: Using microRNAs to target KRAS-addicted cancer.

Jones MF, Hara T, Lal A. Jones MF, et al. RNA Dis. 2015;2(1):e539. doi: 10.14800/rd.539. Epub 2015 Feb 11. RNA Dis. 2015. PMID: 29367950 Free PMC article.

2

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer.

Hiraki M, Nishimura J, Takahashi H, Wu X, Takahashi Y, Miyo M, Nishida N, Uemura M, Hata T, Takemasa I, Mizushima T, Soh JW, Doki Y, Mori M, Yamamoto H. Hiraki M, et al. Mol Ther Nucleic Acids. 2015 Mar 10;4(3):e231. doi: 10.1038/mtna.2015.5. Mol Ther Nucleic Acids. 2015. PMID: 25756961 Free PMC article.

3

miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3.

Zhou Y, Dang J, Chang KY, Yau E, Aza-Blanc P, Moscat J, Rana TM. Zhou Y, et al. Cancer Res. 2016 Oct 1;76(19):5777-5787. doi: 10.1158/0008-5472.CAN-15-2936. Cancer Res. 2016. PMID: 27698189 Free PMC article.

4

MicroRNA profiling differentiates colorectal cancer according to KRAS status.

Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P, Knuutila S. Mosakhani N, et al. Genes Chromosomes Cancer. 2012 Jan;51(1):1-9. doi: 10.1002/gcc.20925. Epub 2011 Sep 15. Genes Chromosomes Cancer. 2012. PMID: 21922590

5

MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.

Angius A, Pira G, Scanu AM, Uva P, Sotgiu G, Saderi L, Manca A, Serra C, Uleri E, Piu C, Caocci M, Ibba G, Zinellu A, Cesaraccio MR, Sanges F, Muroni MR, Dolei A, Cossu-Rocca P, De Miglio MR. Angius A, et al. Int J Med Sci. 2019 Oct 11;16(11):1480-1491. doi: 10.7150/ijms.35269. eCollection 2019. Int J Med Sci. 2019. PMID: 31673240 Free PMC article.

6

RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.

Fang B. Fang B. Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):27-38. doi: 10.1093/abbs/gmv090. Epub 2015 Sep 7. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 26350096 Free PMC article. Review.

7

Defeat mutant KRAS with synthetic lethality.

Pang X, Liu M. Pang X, et al. Small GTPases. 2017 Oct 2;8(4):212-219. doi: 10.1080/21541248.2016.1213783. Epub 2016 Jul 27. Small GTPases. 2017. PMID: 27463838 Free PMC article. Review.

8

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.

Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, Fontanini G, Fassan M, Cappuzzo F, Croce CM. Gasparini P, et al. Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14924-9. doi: 10.1073/pnas.1520329112. Epub 2015 Nov 16. Proc Natl Acad Sci U S A. 2015. PMID: 26627242 Free PMC article.

9

Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer.

Zhong X, Zheng L, Shen J, Zhang D, Xiong M, Zhang Y, He X, Tanyi JL, Yang F, Montone KT, Chen X, Xu C, Xiang AP, Huang Q, Xu X, Zhang L. Zhong X, et al. Mol Cell Biol. 2016 Oct 13;36(21):2742-2754. doi: 10.1128/MCB.00079-16. Print 2016 Nov 1. Mol Cell Biol. 2016. PMID: 27550813 Free PMC article.

10

MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers.

Lundberg IV, Wikberg ML, Ljuslinder I, Li X, Myte R, Zingmark C, Löfgren-Burström A, Edin S, Palmqvist R. Lundberg IV, et al. Anticancer Res. 2018 Feb;38(2):677-683. doi: 10.21873/anticanres.12272. Anticancer Res. 2018. PMID: 29374690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year